Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors-Reference-Cited by-同舟云学术

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors

Published:2022-11-04 Issue:2 Volume:43 Page:280-284
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Chen Zhiwei¹,Zhu Peng²,Liu Zuojin³,Zhu Bin⁴,Yin Guobing⁵,Ming Jia⁵,Song Rui¹,Pan Qingbo¹,Li Tong²,Jiang Xingwei⁶,Wang Bing⁴,Liu Shuaibin⁶,Cai Hongxing²,Wang Jingjie²,Han Yuling⁵,Lin Zijing⁵,Hong Yang⁶,Chen Min¹,Peng Mingli¹,Hu Lina⁶,Cai Dachuan¹,Ren Hong¹^ORCID

Affiliation:

1. Department of Infectious Diseases Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education) Institute for Viral Hepatitis the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

2. Department of Gastrointestinal Surgery the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

3. Department of Hepatobiliary Surgery the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

4. Department of Thoracic and Cardiovascular Surgery the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

5. Department of Breast and Thyroid Surgery the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

6. Department of Gynaecology and Obstetrics Reproductive Medicine Center the Second Affiliated Hospital of Chongqing Medical University Chongqing 400010 P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12368

Reference10 articles.

1. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis

2. The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges